Journal of Bone and Mineral Research
-
Publication Venue For
-
Corrigendum to: Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research (J Bone Miner Res, (2016), 31, (16-35), 10.1002/jbmr.2708).
31:1910.
2016
-
Erratum: Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the American Society for Bone and Mineral Research (Journal of Bone and Mineral Research (2010) 25 (2267-2294)).
26:1987.
2011
-
Long-term control of bone turnover in paget's disease with zoledronic acid and risedronate (Journal of Bone and Mineral Research (2007) 22, (142-148)).
22:773.
2007
-
Long-term control of bone turnover in Paget's disease with zoledronic acid and risedronate..
22:142-148.
2007
-
Medical management of Paget's disease of bone: indications for treatment and review of current therapies..
21 Suppl 2:P94-P98.
2006
-
Bio imaging of intracellular NO production in single bone cells after mechanical stimulation..
21:1722-1728.
2006
-
Combined bone morphogenetic protein-2 and -7 gene transfer enhances osteoblastic differentiation and spine fusion in a rodent model..
19:2021-2032.
2004
-
Unmasking the osteoinductive effects of a G-protein-coupled receptor (GPCR) kinase (GRK) inhibitor by treatment with PTH(1-34)..
19:1661-1670.
2004
-
Soda isn't only low in calcium..
19:870.
2004
-
Chloride channel ClCN7 mutations are responsible for severe recessive, dominant, and intermediate osteopetrosis..
18:1740-1747.
2003
-
Serum FGF23 levels in normal and disordered phosphorus homeostasis..
18:1227-1234.
2003
-
Marrow cell transplantation for infantile hypophosphatasia..
18:624-636.
2003
-
Inhibition of 1,25-dihydroxyvitamin D3-dependent transcription by synthetic LXXLL peptide antagonists that target the activation domains of the vitamin D and retinoid X receptors..
17:2196-2205.
2002
-
Incidence and natural history of Paget's disease of bone in England and Wales..
17:465-471.
2002
-
The loss of Smad3 results in a lower rate of bone formation and osteopenia through dysregulation of osteoblast differentiation and apoptosis..
16:1754-1764.
2001
-
Altered bone mass and microarchitecture in beta-arrestin2 KO mice..
16:S158-S158.
2001
-
Impact of sodium intake and dietary patterns on biochemical markers of bone and calcium metabolism..
16:S511-S511.
2001
-
Inhibition of 1,25-dihydroxyvitamin D3-dependent transcription by synthetic peptide antagonists that target the activation domain of retinoid X receptor..
16:S184-S184.
2001
-
Interplay of nitric oxide synthase (NOS), cyclooxygenase (COX) and lipoxygenase (LOX) pathways in response to mechanical compression of articular cartilage..
16:S330-S330.
2001
-
A clinical approach to diagnosis and management of Paget's disease of bone..
16:1379-1387.
2001
-
Intraosseous meningioma--a mimicry of Paget's disease?.
16:1154-1156.
2001
-
An essential role for Smad3 in bone formation through regulation of osteoblast differentiation..
15:S189-S189.
2000
-
Discussion: Newer bisphosphonates in the treatment of Paget's disease of bone: where we are and where we want to go..
14 Suppl 2:74-78.
1999
-
Factors associated with self-rated health in patients with Paget's disease of bone..
14 Suppl 2:99-102.
1999
-
Leontiasis ossea in secondary hyperparathyroidism..
12:1952-1953.
1997
-
Peyronie's disease is associated with Paget's disease of bone..
12:929-934.
1997
-
Paget's disease of bone and quality of life..
11:1897-1904.
1996
-
Cyclical parathyroid hormone with or without sequential calcitonin or treat osteoporosis: Final results of a 2 year clinical trial.
11:T622-T622.
1996
-
Differential regulation of receptor-stimulated cyclic adenosine monophosphate production by polyvalent cations in MC3T3-E1 osteoblasts..
11:789-799.
1996
-
Treatment with growth hormone and IGF-I in growing rats increases bone mineral content but not bone mineral density..
10:1352-1358.
1995
-
Erratum: Treatment with growth hormone and IGF-I in growing rats increases bone mineral content but not bone mineral density (Journal of Bone and Mineral Research (1995) 10 (1352-1358)).
10:1836.
1995
-
Improved assessment of lumbar vertebral body strength using supine lateral dual-energy x-ray absorptiometry..
9:687-693.
1994
-
Flanking markers define the X-linked hypophosphatemic rickets gene locus..
8:1149-1152.
1993
-
FREQUENT MISDIAGNOSIS OF X-LINKED HYPOPHOS-PHATEMIC RICKETS.
7:S336-S336.
1992
-
LATERAL DUAL ENERGY X-RAY ABSORPTIOMETRY - AN IMPROVED METHOD TO ASSESS VERTEBRAL STRENGTH.
7:S117-S117.
1992
-
RENAL 25-HYDROXYVITAMIN D-1-ALPHA-HYDROXYLASE ACTIVITY FOLLOWING UNINEPHRECTOMY IS REDUCED IN AGED C57BL6J MICE.
7:S169-S169.
1992
-
Teaching patients coping behaviors: an essential part of successful management of osteoporosis..
4:799-801.
1989
-
Equivalency of various methods for estimating osteoid seam width..
4:671-677.
1989
-
1,25-Dihydroxyvitamin D3 stimulates avian and mammalian cartilage growth in vitro..
3:87-91.
1988
-
Disease Characteristics, Disability, and Quality of Life in Adult HPP patients with Muscular Symptoms and Pain without Skeletal Manifestations - A Cross-Sectional Analysis from the Global HPP Registry
2022
-
Interleukin-6 Signaling Mediates Both Cartilage Degradation and Pain in Post-Traumatic Osteoarthritis
2022
-
Prx1Cre Expressing Cells and Their Descendants Form UniqueNon-Myogenic Mesenchymal Cell Populations Within Skeletal Muscle
2022
-
Glutamine Metabolism in Cartilage Tumors
2020
-
Maresin 1 resolves macrophage inflammation to improve aged bone fracture healing
2020
-
Real-World Clinical Profiles of Adults With Hypophosphatasia (HPP) From the Global HPP Registry
2020
-
A Real-World Study of the Patient Experience of Osteoporosis Following Treatment with Abaloparatide
2019
-
A Real-World Study of the Patient Experience of Osteoporosis Following Treatment with Abaloparatide
2019
-
Clinical Burden in Adults with Pediatric-Onset Hypophosphatasia: a Retrospective Chart Review
2019
-
Clinical Burden in Adults with Pediatric-Onset Hypophosphatasia: a Retrospective Chart Review
2019
-
FRAX without BMD predicts treatment recommendations for Veterans who recently sustained a low trauma non-vertebral/non-hip fracture
2019
-
Adults With Hypophosphatasia Enrolled in the Global HPP Registry Have Delayed Diagnosis and Systemic Manifestations of the Disease
2018
-
Burosumab Improved Serum Phosphorus, Osteomalacia, Mobility, and Fatigue in the 48-Week, Phase 2 Study in Adults with Tumor-induced Osteomalacia Syndrome
2018
-
Genetic Variants Associated with Circulating Parathyroid Hormone among Patients with Chronic Kidney Disease
2018
-
The role of apolipoprotein E in fracture healing and osteoblast differentiation
2018
-
A Role for Apolipoprotein E in Fracture Healing.
2017
-
Effects of Burosumab (KRN23), a Human Monoclonal Antibody to FGF23, in Patients with Tumor-Induced Osteomalacia (TIO) or Epidermal Nevus Syndrome (ENS).
2017
-
Increased Ca2+signaling through altered CaV1.2 L-type Ca2+channel activity promotes bone formation and prevents estrogen deficiency-induced bone loss.
2017
-
Micro-environmental Features of the Bone and Bone Marrow Associated with Metastatic Colonization.
2017
-
Murine model for type VI OI (Serpinf1(-/-)) reveals dynamic regulation of vascularization and mineralization in bone.
2017
-
Osteoblast depletion increases osteoblast activity and reduces bone toughness in mice.
2014
-
Rejuvenating Bone Fracture Repair
2013
-
Repeated Osteoblast Depletion Decreases Osteogenic Potential of Bone Marrow Stromal Cells in Mice
2013
-
An Assessment of Serum Calcium and Bone Resorption Markers in Patients Transitioned from Alendronate to Denosumab.
2008
-
Rehabilitation after Clinically-diagnosed Osteoporotic Vertebral Fracture: Results of a Pilot Study.
2008
-
The PTH 1 receptor (PTH1R) Stimulates Bone Formation Through a Distinct beta-Arrestin Dependent Pathway Independent of G Protein Activation
2008
-
Uncarboxylated Osteocalcin is an Endocrine Link between the Skeleton and the Glucose Metabolism: Clinical Evidences from Obese and Post Gastric By-pass Patients
2008
-
G protein-coupled receptor (GPCR) kinase 2 (GRK2) inhibits canonical Wnt signaling.
2006
-
Notch signaling represses osteoblast activity but promotes osteoclast function in vivo.
2006
-
Prevalence and predictors of osteoporosis treatment in nursing home residents with known osteoporosis or recent fracture.
2006
-
The horizon recurrent clinical fracture after recent hip fracture trial (RFT) study cohort description.
2006
-
Distinct conformations of the parathyroid hormone receptor mediate G protein and beta-arrestin dependent activation of ERK1/2.
2005
-
Enhanced bone mass in mice lacking G protein-coupled receptor kinases.
2005
-
Predictors of bone mineral density in patients on antiepileptic drugs.
2005
-
Rates of fracture after stroke in international population-based cohorts.
2005
-
Temporal control of gene deletion in the cartilage using a tamoxifen inducible Cre transgenic mouse.
2005
-
Corpectomy and reconstruction of anterior vertebral body tumors with an expandable cage through a posterior only extracavitary approach
2005
-
Hip and other osteoporotic fractures increase the risk of subsequent fractures in nursing home (NH) residents.
2004
-
Hip fracture trends from 1990-2001: Indirect evidence of improved diagnosis and treatment
2004
-
Overexpression of g protein-coupled receptor kinase 2 (GRK2) in osteoblasts decreases bone mass and reduced the anabolic effects of PTH(1-34).
2004
-
Oxygen, mechanical compression and inflammation in articular cartilage.
2004
-
Severe hypocalcemia in a patient with Paget's disease of bone (PD) treated with bisphosphonate.
2004
-
Prevalence of hypovitaminosis D (vitamin D insufficiency and deficiency) in southern elderly osteoporotic patients.
2003
-
Primary care resident evaluations for chronic health conditions: A failure to assess for osteoporosis
2002
-
Potential of a "whole PTH" assay to improve the discrimination of intraoperative parathyroid hormone assays.
2000
-
Alendronate increases bone mineral density in male idiopathic osteoporosis.
1999
-
Benefits of intraoperative parathyroid hormone monitoring during surgery for hyperparathyroidism.
1996
-
FUNCTIONAL-CHARACTERIZATION OF A CATION SENSING MECHANISM IN OSTEOBLASTS
1995
-
QUANTITATIVE-ANALYSIS OF THE CALCIUM-SENSING RECEPTOR BY COMPETITIVE RT-PCR
1995
-
ROBO-1 - A NOVEL RAT BONE GENE IDENTIFIED BY DIFFERENTIAL DISPLAY PCR
1995